The COVID-19 vaccine made by
The study, conducted by
It determined that antibodies in vaccinated subjects were just as able to neutralize a lab-created version of the mutated coronavirus.
The findings were posted online and have yet to be peer-reviewed, but they offered hope that the approved "messenger RNA" COVID-19 vaccines approved so far will also work to neutralize the variant versions of the SARS-CoV-2 coronavirus.
"I think this [study] is really important, because there is a lot of fear and uncertainty at the moment about this specific question,"
One of the new variants, known as SARS-CoV-2 B.1.1.7, was first identified in
Another variant also emerged independently in
The
Preliminary studies indicate the British variant is associated with increased transmissibility, but there is no evidence so far that they cause more severe illness or increased risk of death.
Copyright 2021 United Press International, Inc. (UPI). Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent., source